Results 161 to 170 of about 848,794 (248)

Sanitation of <i>Staphylococcus aureus</i> genotype B as a model for community of practice for improving food safety and animal health. [PDF]

Front Vet Sci
Romanó A, Graber HU, Fonseca DR, Stoffers H, Matthey N, Teixeira P, Cortez J, Sarquis MA, Bourdichon F, Bassi D, Sartori C, Bacciarini L, Vaccani M, Sesso L, Fuerst SL, Scettrini PR, Reist M, Bachmann HP, Wahl F, Nemati G.   +19 more
europepmc   +1 more source

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan, Marco Pitteri, Michael Foster, Sara Collorone, Sara Salama, Elisa Colato, Ferran Prados, Baris Kanber, Marios Yiannakas, Claudia A. M. Gandini Wheeler‐Kingshott, Indran Davagnanam, Frederik Barkhof, Declan Chard, Olga Ciccarelli, Ahmed Toosy   +14 more
wiley   +1 more source

The causal effects of artificial intelligence use on metacognition, engagement, and knowledge transfer in educational contexts. [PDF]

Front Psychol
Li J.
europepmc   +1 more source

Identification of the Equivalent Model of the Knowledge-Forgetting Process in Every “Forgetting Band”

Visnyk of Vinnytsia Politechnical Institute
B.I. Mokin, О.B. Mokin, О.О. Voitsekhovska, B.V. Pasieka   +3 more
openaire   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Research priority setting for unpaid carers of older adults, patients with palliative care needs and at the end of life in Australia. [PDF]

Palliat Care Soc Pract
Javanparast S, Martin P, Dullow A, Willis A, Omoya O, Tieman J.   +5 more
europepmc   +1 more source

White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng, Diego Z. Carvalho, Shahid Karim, Anwar Chahal, Virend K. Somers   +4 more
wiley   +1 more source

Identifying a program's "core components" using a co-design approach: a methodological worked example from a youth mental health and addictions navigation service. [PDF]

Res Involv Engagem
Sheldrake E, Joshi KY, Rivas S, Algate N, Levitt AJ, Markoulakis R.   +5 more
europepmc   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source